Search results

Selected filters:

Africa & Middle East
Law & Policy

Article type

Topic

Sector

Jurisdictions

13 results found for your search

Sort options
05 December 2019

The search for the world's leading IP strategists is on

IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value

18 November 2019

South Africa's top court issues first patent decision but fails to clarify infringement defence uncertainties

The country’s Constitutional Court, which split down the middle, refused to grant an appeal to challenge a Merck patent on new grounds

07 March 2019

More technology transfer needed for effective climate change mitigation  

Patent focus has shifted to energy storage as cost-effectiveness achieved for wind and solar power, but the failure to address the role of IP hinders transfer mechanisms    

06 March 2019

The state of play in the global IP market

IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy 

23 January 2019

Welcome to the future of patents

New IAM research reports identify the key trends shaping the global IP market – and tell you how to respond

11 January 2019

The global patent market in 10 charts

The key takeaways from WIPO’s 2018 IP indicators report   

20 July 2018

China and South Korea will displace the West as the world’s innovation leaders by 2029

New report claims status of US, EU and UK as leading innovators under threat as they struggle to maximise return on R&D investment. 

07 July 2018

All the big legal, market and deals news from the life sciences sector in June

In June’s round-up of life sciences-related news, we report on the US Supreme Court’s decision to grant certiorari in the Helsinn Healthcare v Teva Pharmaceuticals Section 102 dispute, but not in the Cleveland Clinic’s Section 101 case against True…

15 June 2018

South Africa moves to substantive examination for pharma patents, amid fears system could grind to halt

New IP policy looks to get tough on evergreening in pharma industry but also brings country closer to international best practices. 

06 May 2018

Israel's innovation story is extraordinary, but just assuming it will continue would be a big mistake

Series of unique factors contributed to country's status as start-up hub but there are growing signs that more needs to be done to preserve it. 

08 March 2016

Major sanctions on ZTE may mean tough times ahead for US-Chinese tech collaboration

The US Department of Commerce has reportedly slapped tough restrictions on telecoms giant ZTE, in a move that could end many of its supplier relationships with US tech companies. Effective today, any company that wants to ship US-made hardware to…

28 September 2015

Novartis is the latest Big Pharma player to extend olive branch in Third World patent rights row

While the global quarrel over the pricing of patented drugs continues unabated, Swiss pharmaceutical giant Novartis has announced that it will offer a number of its medicines at significant discount to developing countries. According to a press…

17 June 2015

A new approach to the reform debate; China's IP future; the European tide; and much more at IPBC Global Day 3

IPBC Global in San Francisco is now finished, but only after another compelling day of sessions, networking and discussion. Here, IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – pick out a few of the highlights: …